MedTrace Logo

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

NCT03317886 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 354

Last updated 2017-10-24

No results posted yet for this study

Summary

The aim of this study is to evaluate the advantage of mesenteric approach during pancreaticoduodenectomy (PD) for pancreatic ductal adenocarcinoma (PDAC). The design of this study is multicenter randomized clinical trial, comparing oncological and surgical outcomes between mesenteric approach and conventional approach during PD for PDAC.

Conditions

Interventions

PROCEDURE

pancreaticoduodenectomy

pancreaticoduodenectomy for pancreatic ductal adenocarcinoma

Sponsors & Collaborators

  • Wakayama Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03317886 on ClinicalTrials.gov